HeartSciences Inc. (HSCS)
HeartSciences Inc. (HSCS) Stock Price, Analysis & Data
| Bid | n/a |
| Market Cap | 8.62M |
| Revenue (ttm) | 4.32K |
| Net Income (ttm) | -9.14M |
| Beta | 1.80 |
| EPS (ttm) | -3.73 |
| PE Ratio (ttm) | n/a |
| Forward PE | -1.19 |
| P/B (ttm) | 31.13 |
| P/S (ttm) | 1995.34 |
| Earnings Date | n/a |
| Ask | n/a |
| Volume | 77,114 |
| Avg. Volume (20D) | 2,346,498 |
| Open | 2.06 |
| Previous Close | 2.06 |
| Day's Range | 2.00 - 2.22 |
| 52-Week Range | 1.63 - 3.93 |
| Analyst | n/a |
| Price Target | 10 (352.49%) |
| Dividends | n/a |
| Ex-Dividend Date | n/a |
About HSCS
HeartSciences Inc., a medical technology company, focuses on advancing electrocardiography (ECG) through the integration of artificial intelligence. It develops artificial intelligence-enhanced electrocardiography (AI-ECG) solutions, an algorithm to detect impaired cardiac relaxation or cardiac dysfunction; MyoVista wavECG device, a resting 12-lead ECG that provides diagnostic information related to cardiac dysfunction, as well as conventional EC...
Financial Performance
In 2026, HeartSciences's revenue was 4.32K, a decrease of -0.71% compared to the previous year's 4.35K. Earnings were -9.14M, an increase of 4.3%.
Financial StatementsAnalyst Forecast
According to 2 analyst ratings, the average rating for HSCS stock is "null". The 12-month stock price forecast is 10, which is upside of 352.49% from the latest price.
Stock Forecasts
